Division of Nephrology, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea.
Division of Nephrology, Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea.
Ren Fail. 2021 Dec;43(1):327-334. doi: 10.1080/0886022X.2020.1870137.
Our aim was to elucidate whether Hb variability affects nutritional status in HD patients.
This study included chronic HD patients ( = 76) with available monthly Hb levels up to 24 months prior to the body composition monitoring (BCM) measurement. The parameters obtained in the BCM included body mass index (BMI), lean tissue index (LTI), fat tissue index (FTI), body cell mass index (BCMI), overhydration/extracellular water ratio (OH), and phase angle (PhA). The coefficient of variation (Hb-CV), standard deviation (Hb-SD), and range of Hb (Hb-RAN) were used as indexes of Hb variability. In addition, minimum (Hb-Min), maximum (Hb-Max), average (Hb-Avg), and median (Hb-Med) Hb levels (g/dL) were analyzed.
There were no significant differences in clinical, biochemical, and nutritional indexes based on the Hb-CV level. Compared to patients with an Hb-Med ≤ 10.77, those with an Hb-Med >10.77 had higher albumin levels, total iron-binding capacity (TIBC), and PhA and lower average weekly prescribed darbepoetin. Age, female sex, OH, and darbepoetin dosage were negatively correlated with PhA. Serum albumin, phosphorus, TIBC, Hb-Med, and Hb-Avg were positively correlated with PhA. In multiple linear regression analysis, PhA was positively associated with Hb-Med and serum albumin level, whereas PhA was negatively associated with age and female sex. The area under the curve (AUC) of Hb-Med was 0.665 ( = 0.040) in predicting PhA >5.00°.
PhA was not affected by indexes of Hb variability, whereas PhA was associated with Hb-Med in chronic HD patients.
我们旨在阐明血红蛋白变异性是否会影响血液透析患者的营养状况。
本研究纳入了 76 例有可用的每月血红蛋白水平的慢性血液透析患者,这些水平可追溯至身体成分监测(BCM)测量前 24 个月。BCM 获得的参数包括体重指数(BMI)、瘦组织指数(LTI)、脂肪组织指数(FTI)、细胞内液质量指数(BCMI)、水过量/细胞外液比值(OH)和相位角(PhA)。血红蛋白变异性的指标包括变异系数(Hb-CV)、标准差(Hb-SD)和血红蛋白范围(Hb-RAN)。此外,还分析了最小血红蛋白(Hb-Min)、最大血红蛋白(Hb-Max)、平均血红蛋白(Hb-Avg)和中位血红蛋白(Hb-Med)(g/dL)水平。
根据 Hb-CV 水平,患者的临床、生化和营养指标没有显著差异。与 Hb-Med ≤ 10.77g/dL 的患者相比,Hb-Med >10.77g/dL 的患者白蛋白水平、总铁结合能力(TIBC)和 PhA 更高,每周平均处方的达贝泊汀更少。年龄、女性、OH 和达贝泊汀剂量与 PhA 呈负相关。血清白蛋白、磷、TIBC、Hb-Med 和 Hb-Avg 与 PhA 呈正相关。在多元线性回归分析中,PhA 与 Hb-Med 和血清白蛋白水平呈正相关,而与年龄和女性呈负相关。Hb-Med 预测 PhA >5.00°的曲线下面积(AUC)为 0.665(=0.040)。
PhA 不受血红蛋白变异性指标的影响,而在慢性血液透析患者中,PhA 与 Hb-Med 相关。